Author: Kerecis Communications

Media coverage

Kerecis Fish-Skin Based Treatment Hailed as Groundbreaking

Clinical Study Finds Burn Patients Treated with Kerecis® Omega3 Intact Fish Skin Experienced Pain Relief, Fast Healing and No Infections

Superbones Superwounds East

Catch of the Day: Dr. Lacqua and Kerecis at the 2019 SuperBones SuperWounds East

Dr. Allen Raphael

Tackling the Challenges of Lower Extremity Ulcers

Aurora Award Winner on the Benefits of Participating

Dr. Tracy Zivin-Tutela MD

Using Kerecis Omega3 Wound in Case of Acute Infections

Northern Lights Wound Workshop Wraps up Successfully

President of Iceland Honors Clinicians for Medical Fish Skin Research

Fantastic First Day Completed at the Northern Lights Wound Workshop

Kerecis to acquire Phytoceuticals

Kerecis to Acquire Swiss Life-Science Company Phytoceuticals, Gains Approval of Kerecis Omega3 Wound for Reimbursement in Switzerland

Steve DiBiasio

Kerecis Hires Stephen DiBiasio as Executive Vice President

The Aurora Awards Winners Announced

Aurora Awards Winners Announced

PRESENT Treasure Hunt

Get a Hands-On Experience at the Upcoming PRESENT Treasure Hunt

Miami Herald article

Kerecis Featured in the Miami Herald

MedStar Health to Initiate an IDE Feasibility Trial on Full-Thickness Burn Wounds Treated with Kerecis Omega3 Intact Fish Skin

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.

Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.

Products

Company

Help

© 2010 – 2025 Kerecis. All Rights Reserved